Latest News and Press Releases
Want to stay updated on the latest news?
-
●Q1 2025 revenue increased 4% YoY to $6,770,886 ●Commenced reorganization and strategic shift to regulated market operating profile ●Successfully submitted initial licensing application to...
-
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and...